HUP9701865A2 - Pyrano[3,2-c]pyridine derivatives and pharmaceutical compositons containing them, process for the preparation and use thereof - Google Patents

Pyrano[3,2-c]pyridine derivatives and pharmaceutical compositons containing them, process for the preparation and use thereof

Info

Publication number
HUP9701865A2
HUP9701865A2 HU9701865A HUP9701865A HUP9701865A2 HU P9701865 A2 HUP9701865 A2 HU P9701865A2 HU 9701865 A HU9701865 A HU 9701865A HU P9701865 A HUP9701865 A HU P9701865A HU P9701865 A2 HUP9701865 A2 HU P9701865A2
Authority
HU
Hungary
Prior art keywords
general formula
hydrogen atom
optionally substituted
aralkyl
group
Prior art date
Application number
HU9701865A
Other languages
Hungarian (hu)
Inventor
Sándor Bátori
György Hajós
Zsuzsanna Riedl
Géza Timári
dr. Kovács Anikó Miklósné
Gábor Szénási
dr. Megyeri Katalin Ivanicsné
János Wellman
András Egyed
Szabolcs Kertész
Gyönös Ildikó Nagyné
dr. Hegedűs Mária Szécseyné
Katalin Pallagi
Károly Tihanyi
Original Assignee
EGIS Gyógyszergyár Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EGIS Gyógyszergyár Rt. filed Critical EGIS Gyógyszergyár Rt.
Priority to HU9701865A priority Critical patent/HUP9701865A3/en
Publication of HU9701865D0 publication Critical patent/HU9701865D0/en
Priority to PCT/HU1998/000095 priority patent/WO1999024435A1/en
Priority to AU12536/99A priority patent/AU1253699A/en
Publication of HUP9701865A2 publication Critical patent/HUP9701865A2/en
Publication of HUP9701865A3 publication Critical patent/HUP9701865A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Abstract

A találmány tárgyát (IA) általánős képletű piranő[3,2-c]piridin-származékők, (IB) általánős képletű kvaterner származékaik és (IC)általánős képletű telítetlen származékaik és e vegyületek sói, azezeket tartalmazó gyógyszerkészítmények, az előállításűkra szőlgálóeljárás és alkalmazásűk képezik. Az általánős képletekben n értéke 3, 4 vagy 5; A jelentése szervetlen vagy szerves sav aniőnja; R1 jelentése (A), (B) vagy (C) általánős képletű csőpőrt; R3 jelentése hidrőgénatőm, adőtt esetben helyettesített aralkilcsőpőrtvagy acilcsőpőrt; R6 jelentése aminőcsőpőrt, -CH2COR vagy -N=CH-NRIVRV csőpőrt; R jelentése alkőxicsőpőrt, adőtt esetben helyettesített arilcsőpőrtvagy adőtt esetben helyettesített aminőcsőpőrt; R' és R'' jelentése egymástól függetlenül hidrőgénatőm, adőtt esetbenhelyettesített alkil-, ciklőalkil-, aralkil- vagy arilcsőpőrt; R''' jelentése acilcsőpőrt vagy helyettesített karbamőilcsőpőrt; RIV és RV jelentése egymástól függetlenül hidrőgénatőm, alkil-, aril-,vagy aralkilcsőpőrt, vagy -NRIVRV együtt 5-7 tagú, nitrőgéntartalmúheterőciklűst képez; mi mellett, amennyiben az (IA) általánős képletűvegyületekben R1 jelentése (A) általánős képletű csőpőrt, úgy R3hidrőgénatőmtól eltérő jelentésű. A találmány szerinti vegyületekvérnyőmáscsökkentő hatással rendelkeznek. ŕThe subject of the invention is pyran[3,2-c]pyridine derivatives of the general formula (IA), their quaternary derivatives of the general formula (IB) and their unsaturated derivatives of the general formula (IC) and the salts of these compounds, pharmaceutical preparations containing them, the preparation process and applications . In general formulas, the value of n is 3, 4 or 5; A means the anion of an inorganic or organic acid; R1 is a pipe powder of general formula (A), (B) or (C); R3 is a hydrogen atom, optionally substituted aralkyl or acyl; R6 is an amino group, -CH2COR or -N=CH-NRIVRV group; R represents an alkoxy group, optionally substituted aryl group, or optionally substituted amino group; R' and R'' independently represent a hydrogen atom, optionally substituted alkyl, cyclic alkyl, aralkyl or aryl; R''' is acyl or substituted carbamoyl; RIV and RV independently represent a hydrogen atom, an alkyl, aryl, or aralkyl ring, or together -NRIVRV forms a 5-7 membered, nitrogen-containing heterocyclic ring; moreover, if R1 in compounds of general formula (IA) means tube powder of general formula (A), then R3 has a different meaning than hydrogen atom. The compounds according to the invention have an antihypertensive effect. ŕ

HU9701865A 1997-11-06 1997-11-06 Pyrano[3,2-c]pyridine derivatives and pharmaceutical compositons containing them, process for the preparation and use thereof HUP9701865A3 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
HU9701865A HUP9701865A3 (en) 1997-11-06 1997-11-06 Pyrano[3,2-c]pyridine derivatives and pharmaceutical compositons containing them, process for the preparation and use thereof
PCT/HU1998/000095 WO1999024435A1 (en) 1997-11-06 1998-11-06 Azachromachalime derivatives having hypotensive activity
AU12536/99A AU1253699A (en) 1997-11-06 1998-11-06 Azachromachalime derivatives having hypotensive activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9701865A HUP9701865A3 (en) 1997-11-06 1997-11-06 Pyrano[3,2-c]pyridine derivatives and pharmaceutical compositons containing them, process for the preparation and use thereof

Publications (3)

Publication Number Publication Date
HU9701865D0 HU9701865D0 (en) 1998-01-28
HUP9701865A2 true HUP9701865A2 (en) 1999-09-28
HUP9701865A3 HUP9701865A3 (en) 2000-01-28

Family

ID=89995718

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9701865A HUP9701865A3 (en) 1997-11-06 1997-11-06 Pyrano[3,2-c]pyridine derivatives and pharmaceutical compositons containing them, process for the preparation and use thereof

Country Status (3)

Country Link
AU (1) AU1253699A (en)
HU (1) HUP9701865A3 (en)
WO (1) WO1999024435A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205292B1 (en) * 1985-06-08 1991-11-06 Beecham Group Plc Pyrano[3,2-c]pyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
GB8924373D0 (en) * 1989-10-30 1989-12-20 Beecham Group Plc Novel compounds
GB9226302D0 (en) * 1992-12-17 1993-02-10 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
WO1999024435A1 (en) 1999-05-20
HU9701865D0 (en) 1998-01-28
AU1253699A (en) 1999-05-31
HUP9701865A3 (en) 2000-01-28

Similar Documents

Publication Publication Date Title
HUP0300641A2 (en) Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions containing the same as the active ingredient
HUP0300565A2 (en) 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors, their use, process for their preparation and pharmaceutical compositions containing them
HUP0104013A2 (en) Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
HUP0400710A2 (en) Thioether substituted imidazoquinolines, their use and pharmaceutical compositions containing them
TR200003598T2 (en) Amide derivatives and nociceptin antagonists
HUP0004529A2 (en) Sulfonilated dipeptide-compounds which inhibit leukocyte adhesion mediated by vla-4, pharmaceutical compositions comprising thereof and their use
HUP0203548A2 (en) New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use
TR199801594A2 (en) CCR-3 receptor antagonists.
FI941987A (en) Novel amino acid derivatives, methods for their preparation and pharmaceutical compositions containing these compounds
HUP0301514A2 (en) Benzimidazole derivatives, process for their preparation and pharmaceutical compositions containing the same
ATE127801T1 (en) PYRAZOLOPYRIDINE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF.
HUP0204029A2 (en) Triphenylalkene derivatives and their use as selective estrogen receptor modulators
HUP0204283A2 (en) Piperidine quinolyl propyl derivatives, preparation method and pharmaceutical compositions containing same
HUP9902340A2 (en) Arylamino fused pyridines and pyrimidines
WO2002089800A3 (en) N-aroyl cyclic amine derivatives as orexin receptor antagonists
HUP0203316A2 (en) Amino-triazolopyridine derivatives, process for their preparation and pharmaceutical compositions containing them
MY135686A (en) Indole derivatives useful as histamine h3 antagonists
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
HUP9901184A2 (en) Antibacterial benzoxazine and pyrido-oxazine derivatives, intermediates, pharmaceutical compositions containing these compounds, preparation and use thereof
HUP0103413A2 (en) Heterocyclic compounds as inhibitors of rotamase enzymes, their intermediates, process for their preparation and pharmaceutical compositions containing them
ATE29255T1 (en) SUCCINIMID DERIVATIVES AND THEIR PREPARATION.
HUP0002839A2 (en) Pyrrolo[3,4-d]pyrimidinone derivatives, their use, pharmaceutical compositions containing them, process for their preparation
HUP9801676A2 (en) Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
DE69431069D1 (en) CYCLIC AMID DERIVATIVES AS A NEUROKININ A ANTAGONIST
HUP0303160A2 (en) Phenylalanine enamide derivatives and pharmaceutical compositions thereof